RxDoctor Payments Data

John Wall, MD

Family Medicine · Milwaukee, WINPI 1942317292

Payments from drug & device makers

$441in general payments, 2019–2025

Across 22 payments — averaging $20.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$52
  • AbbVie$49
  • AstraZeneca$48
  • Nestle Healthcare Nutrition Inc.$48
  • Boehringer Ingelheim$40
  • Exact Sciences$28
  • plus $176 from 9 others

What the payments were for

  • Food & beverage$441100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$441 in reported general payments places this provider in the 80th percentile of 1,482 family medicine providers in Wisconsin.

See all family medicine providers in Wisconsin

Medicare billing

Part B allowed, 2024
$291
Medicare patients
12
Services billed
15

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin100$111,388
LinzessLinaclotide103$86,155
JanuviaSitagliptin Phosphate70$81,630
EliquisApixaban104$77,707
TrulicityDulaglutide47$45,273
Spiriva HandihalerTiotropium Bromide70$44,498
TradjentaLinagliptin36$43,274
OzempicSemaglutide42$39,690
EntrestoSacubitril/Valsartan41$31,200
FarxigaDapagliflozin Propanediol28$30,328
Trelegy ElliptaFluticasone/Umeclidin/Vilanter42$27,126
SymbicortBudesonide/Formoterol Fumarate113$26,058
Combivent RespimatIpratropium/Albuterol Sulfate48$24,173
Breo ElliptaFluticasone/Vilanterol52$22,717
Albuterol Sulfate HfaAlbuterol Sulfate783$15,887

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta, Combivent Respimat$40$178,835184 claims
AstraZenecaFarxiga, Symbicort, Breztri Aerosphere, Brilinta$48$86,536186 claims
AbbVieLinzess$49$86,155103 claims
MerckJanuvia$17$81,63070 claims
PfizerEliquis$52$77,707104 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$21$61,171118 claims
Novo NordiskOzempic$21$39,69042 claims
Astellas Pharma US IncMyrbetriq$22$7,18914 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,482 family medicine providers in Wisconsin.

Other family medicine in Milwaukee

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →